Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Kidney Failure Therapy
Reports from University of Lubeck, Department of Anesthesiology describe recent advances in kidney failure therapy
July 6th, 2009
Researchers detail in 'Urodilatin and pentoxifylline prevent the early onset of Escherichia coli-Induced acute renal failure in a model of isolated perfused rat kidney,' new data in kidney failure. "Raised cytokine levels and a hypoperfusion-associated decrease in glomerular filtration rate (GFR) are hallmarks of the genesis of septic acute renal failure (ARF). Therefore, anti-inflammatory as well as renal vasodilating therapeutic strategies may afford renal protection during septic ARF," scientists writing in the journal Kidney and Blood Pressure Research report. "The present study was designed to determine the effects of administration of urodilatin,...
Source: Biotech Business Week (2009-07-06)
|
